Pregled bibliografske jedinice broj: 733515
Holt Oram syndrome: a registry-based study in Europe
Holt Oram syndrome: a registry-based study in Europe // Orphanet Journal of Rare Disease, 9 (2014), 156-156 (podatak o recenziji nije dostupan, članak, ostalo)
CROSBI ID: 733515 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Holt Oram syndrome: a registry-based study in Europe
Autori
Barisic, I ; Boban, L ; Greenlees, R ; Garne, E ; Wellesley, D ; Calzolari, E ; Addor, MC ; Arriola, L ; Bergman, J ; Braz, P ; Budd, JL ; Gatt, M ; Haeusler, M ; Khoshnood, B ; Klungsoyr, K ; McDonnell, B ; Nelen, V ; Pierini, A ; Queisser- Wahrendorf, A ; Rankin, J ; Rissmann, A ; Rounding, C ; Tucker, D ; Verellen-Dumoulin, C ; Dolk, H
Izvornik
Orphanet Journal of Rare Disease (1750-1172) 9
(2014);
156-156
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
Holt Oram syndrome; Congenital anomalies; Prenatal diagnosis; Epidemiology; Europe
Sažetak
Background: Holt-Oram syndrome (HOS) is an autosomal dominant disorder characterised by upper limb anomalies and congenital heart defects. We present epidemiological and clinical aspects of HOS patients using dana from EUROCAT (European Surveillance of Congenital Anomalies) registries. Methods: The study was based on data collected during 1990–2011 by 34 registries. The registries are populationbased and use multiple sources of information to collect data on all types of birth using standardized definitions, methodology and coding. Diagnostic criteria for inclusion in the study were the presence of radial ray abnormalities and congenital heart disease (CHD), or the presence of either radial ray anomaly or CHD, with family history of HOS. Results: A total of 73 cases of HOS were identified, including 11 (15.1%) TOPFA and 62 (84.9%) LB. Out of 73 HOS cases, 30.8% (20/65) were suspected prenatally, 55.4% (36/65) at birth, 10.7% (7/65) in the first week of life, and 3.1% (2/65) in the first year of life. The prenatal detection rate was 39.2% (20/51), with no significant change over the study period. In 55% (11/20) of prenatally detected cases, parents decided to terminate pregnancy. Thumb anomalies were reported in all cases. Agenesis/hypoplasia of radius was present in 49.2% (30/61), ulnar aplasia/hypoplasia in 24.6% (15/61) and humerus hypoplasia/phocomelia in 42.6% (26/61) of patients. Congenital heart defects (CHD) were recorded in 78.7% (48/61) of patients. Isolated septal defects were present in 54.2 (26/48), while 25% (12/48) of patients had complex/severe CHD. The mean prevalence of HOS diagnosed prenatally or in the early years of life in European registries was 0.7 per 100, 000 births or 1:135, 615 births. Conclusions: HOS is a rare genetic condition showing regional variation in its prevalence. It is often missed prenatally, in spite of the existence of major structural anomalies. When discovered, parents in 45% (9/20) of cases opt for the continuation of pregnancy. Although a quarter of patients have severe CHD, the overall first week survival is very good, which is important information for counselling purposes.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
072-1083107-0365 - Istraživanje epidemiologijskih i genetičkih osnova prirođenih mana (Barišić, Ingeborg, MZOS ) ( CroRIS)
Ustanove:
Klinika za dječje bolesti Medicinskog fakulteta
Profili:
Ingeborg Barišić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE